Full Name
Motomi Osato
(not current staff)
Variants
Osato, M.
MOTOMI OSATO
 
 
 
Email
csimo@nus.edu.sg
 

Publications

Refined By:
Department:  DEAN'S OFFICE (MEDICINE)

Results 1-5 of 5 (Search time: 0.005 seconds).

Issue DateTitleAuthor(s)
11-Sep-2020ASLAN003, a potent dihydroorotate dehydrogenase inhibitor for differentiation of acute myeloid leukemia.Zhou, Jianbiao ; Yiying Quah, Jessie ; Ng, Yvonne ; Chooi, Jing-Yuan ; Hui-Min Toh, Sabrina ; Lin, Baohong; Zea Tan, Tuan ; Hosoi, Hiroki ; Osato, Motomi ; Seet, Qihui; Ooi, Lisa AG; Lindmark, Bertil; McHale, Mark; Chng, Wee-Joo 
22018Preleukemic and second-hit mutational events in an acute myeloid leukemia patient with a novel germline RUNX1 mutationNg, I.K.S; Lee, J; Ng, C; Kosmo, B; Chiu, L; Seah, E; Mok, M.M.H ; Tan, K; Osato, M ; Chng, W.-J ; Yan, B; Tan, L.K 
32019Rap1 regulates hematopoietic stem cell survival and affects oncogenesis and response to chemotherapyKhattar, E.; Maung, K.Z.Y.; Chew, C.L.; Ghosh, A.; Mok, M.M.H. ; Lee, P. ; Zhang, J.; Chor, W.H.J.; Cildir, G.; Wang, C.Q.; Mohd-Ismail, N.K.; Chin, D.W.L. ; Lee, S.C. ; Yang, H. ; Shin, Y.-J.; Nam, D.-H.; Chen, L.; Kumar, A.P. ; Deng, L.W. ; Ikawa, M.; Gunaratne, J.; Osato, M. ; Tergaonkar, V. 
41-Oct-2017RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYCSelvarajan, V ; Osato, M ; Nah, GSS ; Yan, J ; Chung, T-H ; Voon, DC-C ; Ito, Y ; Ham, MF; Salto-Tellez, M ; Shimizu, N; Choo, S-N; Fan, S; Chng, W-J ; Ng, S-B 
530-Mar-2021Super-enhancers for RUNX3 are required for cell proliferation in EBV-infected B cell linesHosoi, Hiroki ; Niibori-Nambu, Akiko; Nah, Giselle Sek Suan; Bahirvani, Avinash Govind ; Mok, Michelle Meng Huang ; Sanda, Takaomi ; Kumar, Alan Prem ; Tenen, Daniel G ; Ito, Yoshiaki; Sonoki, Takashi; Osato, Motomi